Welcome to Cato Research
Cato Research is a full-service contract research and development organization with international resources dedicated to helping pharmaceutical and biotechnology companies efficiently and expeditiously navigate the regulatory approval process in order to bring new drugs, biologics, and medical devices to the people who need them.
» Cato Research Overview | Contact Us
Announcements
- Cato Research congratulates and welcomes Matt Medlin, Ph.D., on recently completing his fellowship in the Fellows Program. Dr. Medlin accepted the position of "Regulatory Scientist I" with the CATO Regulatory Team. He states, "What makes the opportunity extra special, is the company and people I am privileged to work with."
- Cato Research is a proud member of the BIOCOM CRO Initiative!
Recent Posts
- May 21, 2013 - New FDA Guidances for April 2013 – There were many new Guidances out in April. Notably, changes in postmarketing periodic safety reporting are discussed in this guidance. See CATO’s take on some of the changes in postmarket reporting here. [...]
- May 1, 2013 - New Guidance: Formal FDA Meetings for Biosimilar Product Development – On 01 April 2013, the FDA released its fourth guidance regarding the development of biosimilar products: Formal Meetings Between the FDA and Biosimilar Biological Product Sponsors or Applicants. [...]
- March 11, 2013 - The Dawn of a New Clinical Paradigm in the Land of the Rising Sun – A major milestone in the use of stem cells in human therapies was reached in February of 2013. [...]
- More Posts...
Events & News
- May 19-21, 2013 - Optimizing Clinical Research Performance
- May 31-June 4, 2013 - ASCO 2013: Building Bridges to Conquer Cancer
- June 10-12, 2013 - The International Biotechnology Conference, IATI-BioMed Israel
- June 12-14, 2013 - CALBIO 2013: Success Redefined
- More Events...
April 15, 2013 - Cancer Advances Announces Issuance of Three New Patents to Its Suite of Gastrin Inhibitor Products
January 22, 2013 - Cato Research and Cato BioVentures Announces the Opening of Houston, Texas, Office
January 7, 2013 - Join Cato BioVentures and Cancer Advances at Biotech Showcase 2013 & J.P. Morgan 31st Annual Healthcare Conference
- More News...